David B. Zhen
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Gloria M. Petersen (3 shared papers)Vaibhav Sahai (8 shared papers)Mark M. Zalupski (8 shared papers)Paul Swiecicki (2 shared papers)Morie A. Gertz (2 shared papers)Steven R. Zeldenrust (2 shared papers)Michelle L. Mauermann (2 shared papers)Kent A. Griffith (7 shared papers)
- Journals
- Journal of Clinical Oncology (21 papers)Annals of Oncology (3 papers)Cancer Research (2 papers)Cancer (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesJapanPoland
In The Last Decade
David B. Zhen
35 papers receiving 634 citations
Peers
Comparison fields: 5 of 57
- Oncology 432
- Cancer Research 227
- Pathology and Forensic Medicine 77
- Molecular Biology 276
- Surgery 156
Countries citing papers authored by David B. Zhen
This map shows the geographic impact of David B. Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Zhen more than expected).
Fields of papers citing papers by David B. Zhen
This network shows the impact of papers produced by David B. Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Zhen. The network helps show where David B. Zhen may publish in the future.
Co-authors
The 25 scholars most cited alongside David B. Zhen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 203 | |
| 2 | 2015 | 70 | |
| 3 | 2016 | 65 | |
| 4 | 2022 | 42 | |
| 5 | 2020 | 28 | |
| 6 | 2016 | 27 | |
| 7 | 2019 | 26 | |
| 8 | 2014 | 25 | |
| 9 | 2022 | 19 | |
| 10 | 2023 | 18 | |
| 11 | 2022 | 15 | |
| 12 | 2022 | 13 | |
| 13 | 2023 | 13 | |
| 14 | 2023 | 11 | |
| 15 | 2022 | 8 | |
| 16 | 2023 | 7 | |
| 17 | 2020 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2018 | 5 | |
| 20 | 2023 | 5 |
About David B. Zhen
David B. Zhen is a scholar working on Oncology, Surgery, Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 646 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (19 papers), Cancer Genomics and Diagnostics (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Cancer Immunotherapy and Biomarkers (6 papers), Neuroendocrine Tumor Research Advances (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Peptidase Inhibition and Analysis (4 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Oncology (432 citations), Cancer Research (227 citations), Pathology and Forensic Medicine (77 citations), Molecular Biology (276 citations) and Surgery (156 citations). David B. Zhen has collaborated with scholars based in United States, Japan and Poland. Frequent co-authors include Gloria M. Petersen, Vaibhav Sahai, Mark M. Zalupski, Paul Swiecicki, Morie A. Gertz, Steven R. Zeldenrust, Michelle L. Mauermann, Kent A. Griffith, Angela Dispenzieri and Anne-Renee Hartman. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.